Results 221 to 230 of about 116,176 (290)

Prognostic significance of PD-L1/PD-1 co-expression and CXCR3-driven inflammatory signatures in Egyptian patients with lymphoproliferative neoplasms. [PDF]

World J Clin Oncol
Sherief DE, Nosair N, Abdelhameed AM, Sadaka E, Othman AAA, Elgamal R.   +5 more
europepmc   +1 more source

Immune‐related toxicity profile after haematopoietic stem cell transplantation in patients with B‐ALL given combination immunotherapy with rituximab, inotuzumab and blinatumomab

British Journal of Haematology, EarlyView.
Olayinka Okeleji, David McCall, Branko Cuglievan, Amber Gibson, Demetrios Petropoulos, Priti Tewari, Jeremy Connors, Irtiza N. Sheikh   +7 more
wiley   +1 more source

Cryptococcid Sweet Syndrome in the Setting of Hydralazine‐Induced ANCA Vasculitis: A Case Report

Journal of Cutaneous Pathology, EarlyView.
ABSTRACT Acute febrile neutrophilic dermatosis, also known as Sweet syndrome, is an inflammatory skin condition characterized by the rapid onset of painful, erythematous plaques or nodules with neutrophilic infiltrate on histology. Rarely, acellular bodies surrounded by vacuolated spaces have been noted within the neutrophilic infiltrate, mimicking ...
Jenna Vroman, Pelin Sagut, Kathryn Lynam, Amanda Ederle, Laura Winterfield   +4 more
wiley   +1 more source

PDCD1 as a targetable immune checkpoint hub: therapeutic insights for ibrutinib-resistant CLL management. [PDF]

Clin Exp Med
Kalaki NS, Karimi E, Allaei Rouzbahani K, Ahmadzadeh M, Akrami SM.   +4 more
europepmc   +1 more source

High‐throughput monoclonal gammopathy community monitoring programme

British Journal of Haematology, EarlyView.
Gaurav Agarwal, Lauren Campbell, Oluremi Carty, Jemma Larham, Elizabeth Knight, Sally Moore, Sarah Gooding, Jaimal Kothari, Joe Browning, Julia Evans, Lisa Ferguson, Ana Vieira, Liam Swanborough, Pamela Roberts, Elizabeth Bateman, Ross Sadler, Karthik Ramasamy   +16 more
wiley   +1 more source

The Role of SAMHD1 in Viral Resistance and Transduction Efficiency Challenges in Pediatric Hematological Malignancies: Mechanistic Insights and Clinical Perspectives

European Journal of Haematology, EarlyView.
SAMHD1 regulates intracellular dNTP pools, influencing lentiviral transduction, gene therapy efficiency, and disease progression in pediatric hematological malignancies. Integrated bioinformatics and targeted strategies, including CRISPR and pharmacological inhibition, highlight its therapeutic potential.
Waseem Alzamzami
wiley   +1 more source

The Impact of Surface CD20 Expression and Soluble CD20 Levels on In Vivo Cell Fragility in Chronic Lymphocytic Leukemia. [PDF]

J Clin Med
Candan O, Tatli I, Bakisli A, Kula B, Korkut E, Yildirim ME, Gurbuz MA, Yilmaz AF, Atagunduz I, Tuglular AT, Toptas T.   +10 more
europepmc   +1 more source

Factors Affecting Immune Reconstitution Post‐Allogeneic HSCT in Children: The Case for an Individualized Approach to Vaccination

European Journal of Haematology, EarlyView.
ABSTRACT Allogeneic hematopoietic stem cell transplantation (HSCT) is increasingly used to treat malignant and non‐malignant diseases. Following allogeneic HSCT, patients are particularly vulnerable to vaccine‐preventable diseases (VPD) because conditioning depletes immune cells, including memory cells.
Hélène Buvelot, Frederic Baleydier, Laure Pittet, Geraldine Blanchard‐Rohner   +3 more
wiley   +1 more source

Intrathoracic manifestations of hematologic malignancies: a narrative review. [PDF]

Ann Transl Med
Bhyravabhotla K, Gaskey G, Walder JR, Balachandran DD, Cherian SV, Zafar B, Bashoura L, Sheshadri A, Faiz SA.   +8 more
europepmc   +1 more source

Efficacy and Safety of Donor Lymphocyte Infusion After Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Patients

European Journal of Haematology, EarlyView.
ABSTRACT This retrospective study evaluates the efficacy and safety of donor lymphocyte infusion (DLI) after allogeneic hematopoietic stem cell transplantation (HSCT) in children. We describe the long‐term use of preemptive, prophylactic, and therapeutic DLI with a gradual dose increase in half‐log increments.
Dinah Walther, Jana Ernst, Carola Wollenhaupt, Susan Wittig, Manuela Härtel, Grit Brodt, Till Milde, Bernd Gruhn   +7 more
wiley   +1 more source